[Preclinical AD and Biomarker; from J-ADNI to AMED Preclinical Study].

  • Kazushi Suzuki
  • Published 2017 in Brain and nerve = Shinkei kenkyu no shinpo

Abstract

Alzheimer's disease (AD) is most prevalent cause of dementia and no cure has been discovered. Although the framework of AD clinical trials is being established utilizing results of large-scale observational studies such as the AD Neuroimaging Initiative (ADNI) and the Japanese-ADNI (J-ADNI), the development of disease-modifying therapy for Alzheimer's… (More)
DOI: 10.11477/mf.1416200810

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.